soul trial oral semaglutide cardiovascular outcomes 2025 results 🧿 is the first oral GLP-1 RA proven to reduce MACE in high-risk T2DM patients, extending protection beyond injectable formulations. Trial: Oral Semaglutide & Cardiovascular in T2DM The SOUL Study - by

Figure 2 shows that the biphasic PK profile obtained from the two-compartment model is consistent with intravenous data and, furthermore, that the rate of absorption as well as the maximum concentration following subcutaneous doses of different strengths were well captured by the model

[7] [8] Additional risk factors include renal impairment, which can alter medication clearance and glucose homeostasis, and hepatic dysfunction, which affects gluconeogenesis and glucose regulation

InjectaMax is a multi-mineral injection for cattle that contains copper, manganese, zinc, selenium and vitamin B12

Semaglutide, including brands like Wegovy and Ozempic, is a medication that mimics a hormone in the body that helps regulate blood sugar and feelings of fullness

The staff is amazing as well

Access to generic compounded GLP-1 medications (semaglutide) , which are not FDA-approved but are produced by USP-compliant, state-regulated pharmacies partnered with Noom